Hogan Lovells advises Medicud on the seed round with international investors

The transaction primarily involved international investors, including the U.S. fund CHMBR Investment Partners 1 LLC, the French fund FPCI 50 Partners Capital Health and BADGE Business Angels des Grandes Ecoles, to support the growth of the company and the further development of its advanced technological solutions for the medical sector.       

This investment aligns with Medicud's development strategy, which focuses on international expansion.             

The Hogan Lovells team that advised Medicud was led by counsel Pierluigi Feliciani with support from trainee Paola Rossi.